0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hydromorphone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-26V8157
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Hydromorphone Market Insights Forecast to 2028
BUY CHAPTERS

Hydromorphone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26V8157
Report
November 2024
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hydromorphone - Market Size

The global market for Hydromorphone was estimated to be worth US$ 1053 million in 2023 and is forecast to a readjusted size of US$ 1438.1 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030

Hydromorphone - Market

Hydromorphone - Market

Hydromorphone, also known as dihydromorphinone, and sold under the brand name Dilaudid among others, is an opioid used to treat moderate to severe pain. Typically, long-term use is only recommended for pain due to cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hydromorphone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydromorphone by region & country, by Type, and by Application.
The Hydromorphone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydromorphone.
Market Segmentation

Scope of Hydromorphone - Market Report

Report Metric Details
Report Name Hydromorphone - Market
Forecasted market size in 2030 US$ 1438.1 million
CAGR 4.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Injection
Segment by Application
  • Hospital
  • Drug Store
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Purdue Pharma, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Mallinckrodt, Teva Pharmaceuticals, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Hydromorphone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Hydromorphone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Hydromorphone in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Hydromorphone - Market size in 2030?

Ans: The Hydromorphone - Market size in 2030 will be US$ 1438.1 million.

Who are the main players in the Hydromorphone - Market report?

Ans: The main players in the Hydromorphone - Market are Purdue Pharma, Akorn, Barr Pharmaceuticals, Pfizer, Watson Laboratories, Mallinckrodt, Teva Pharmaceuticals, KV Pharmaceutical, Lannett, Apotex, Fresenius, Johnson and Johnson, Mundipharma, Novartis, Stada Arzneimittel, Mylan

What are the Application segmentation covered in the Hydromorphone - Market report?

Ans: The Applications covered in the Hydromorphone - Market report are Hospital, Drug Store

What are the Type segmentation covered in the Hydromorphone - Market report?

Ans: The Types covered in the Hydromorphone - Market report are Oral, Injection

1 Market Overview
1.1 Hydromorphone Product Introduction
1.2 Global Hydromorphone Market Size Forecast
1.2.1 Global Hydromorphone Sales Value (2019-2030)
1.2.2 Global Hydromorphone Sales Volume (2019-2030)
1.2.3 Global Hydromorphone Sales Price (2019-2030)
1.3 Hydromorphone Market Trends & Drivers
1.3.1 Hydromorphone Industry Trends
1.3.2 Hydromorphone Market Drivers & Opportunity
1.3.3 Hydromorphone Market Challenges
1.3.4 Hydromorphone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hydromorphone Players Revenue Ranking (2023)
2.2 Global Hydromorphone Revenue by Company (2019-2024)
2.3 Global Hydromorphone Players Sales Volume Ranking (2023)
2.4 Global Hydromorphone Sales Volume by Company Players (2019-2024)
2.5 Global Hydromorphone Average Price by Company (2019-2024)
2.6 Key Manufacturers Hydromorphone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hydromorphone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hydromorphone
2.9 Hydromorphone Market Competitive Analysis
2.9.1 Hydromorphone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hydromorphone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydromorphone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.2 Global Hydromorphone Sales Value by Type
3.2.1 Global Hydromorphone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hydromorphone Sales Value, by Type (2019-2030)
3.2.3 Global Hydromorphone Sales Value, by Type (%) (2019-2030)
3.3 Global Hydromorphone Sales Volume by Type
3.3.1 Global Hydromorphone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hydromorphone Sales Volume, by Type (2019-2030)
3.3.3 Global Hydromorphone Sales Volume, by Type (%) (2019-2030)
3.4 Global Hydromorphone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Hydromorphone Sales Value by Application
4.2.1 Global Hydromorphone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hydromorphone Sales Value, by Application (2019-2030)
4.2.3 Global Hydromorphone Sales Value, by Application (%) (2019-2030)
4.3 Global Hydromorphone Sales Volume by Application
4.3.1 Global Hydromorphone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hydromorphone Sales Volume, by Application (2019-2030)
4.3.3 Global Hydromorphone Sales Volume, by Application (%) (2019-2030)
4.4 Global Hydromorphone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hydromorphone Sales Value by Region
5.1.1 Global Hydromorphone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hydromorphone Sales Value by Region (2019-2024)
5.1.3 Global Hydromorphone Sales Value by Region (2025-2030)
5.1.4 Global Hydromorphone Sales Value by Region (%), (2019-2030)
5.2 Global Hydromorphone Sales Volume by Region
5.2.1 Global Hydromorphone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hydromorphone Sales Volume by Region (2019-2024)
5.2.3 Global Hydromorphone Sales Volume by Region (2025-2030)
5.2.4 Global Hydromorphone Sales Volume by Region (%), (2019-2030)
5.3 Global Hydromorphone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hydromorphone Sales Value, 2019-2030
5.4.2 North America Hydromorphone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hydromorphone Sales Value, 2019-2030
5.5.2 Europe Hydromorphone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hydromorphone Sales Value, 2019-2030
5.6.2 Asia Pacific Hydromorphone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hydromorphone Sales Value, 2019-2030
5.7.2 South America Hydromorphone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hydromorphone Sales Value, 2019-2030
5.8.2 Middle East & Africa Hydromorphone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hydromorphone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hydromorphone Sales Value
6.2.1 Key Countries/Regions Hydromorphone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hydromorphone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hydromorphone Sales Value, 2019-2030
6.3.2 United States Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hydromorphone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hydromorphone Sales Value, 2019-2030
6.4.2 Europe Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hydromorphone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hydromorphone Sales Value, 2019-2030
6.5.2 China Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hydromorphone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hydromorphone Sales Value, 2019-2030
6.6.2 Japan Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hydromorphone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hydromorphone Sales Value, 2019-2030
6.7.2 South Korea Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hydromorphone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hydromorphone Sales Value, 2019-2030
6.8.2 Southeast Asia Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hydromorphone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hydromorphone Sales Value, 2019-2030
6.9.2 India Hydromorphone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hydromorphone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Purdue Pharma
7.1.1 Purdue Pharma Company Information
7.1.2 Purdue Pharma Introduction and Business Overview
7.1.3 Purdue Pharma Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Purdue Pharma Hydromorphone Product Offerings
7.1.5 Purdue Pharma Recent Development
7.2 Akorn
7.2.1 Akorn Company Information
7.2.2 Akorn Introduction and Business Overview
7.2.3 Akorn Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Akorn Hydromorphone Product Offerings
7.2.5 Akorn Recent Development
7.3 Barr Pharmaceuticals
7.3.1 Barr Pharmaceuticals Company Information
7.3.2 Barr Pharmaceuticals Introduction and Business Overview
7.3.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Barr Pharmaceuticals Hydromorphone Product Offerings
7.3.5 Barr Pharmaceuticals Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Hydromorphone Product Offerings
7.4.5 Pfizer Recent Development
7.5 Watson Laboratories
7.5.1 Watson Laboratories Company Information
7.5.2 Watson Laboratories Introduction and Business Overview
7.5.3 Watson Laboratories Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Watson Laboratories Hydromorphone Product Offerings
7.5.5 Watson Laboratories Recent Development
7.6 Mallinckrodt
7.6.1 Mallinckrodt Company Information
7.6.2 Mallinckrodt Introduction and Business Overview
7.6.3 Mallinckrodt Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mallinckrodt Hydromorphone Product Offerings
7.6.5 Mallinckrodt Recent Development
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Company Information
7.7.2 Teva Pharmaceuticals Introduction and Business Overview
7.7.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Teva Pharmaceuticals Hydromorphone Product Offerings
7.7.5 Teva Pharmaceuticals Recent Development
7.8 KV Pharmaceutical
7.8.1 KV Pharmaceutical Company Information
7.8.2 KV Pharmaceutical Introduction and Business Overview
7.8.3 KV Pharmaceutical Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.8.4 KV Pharmaceutical Hydromorphone Product Offerings
7.8.5 KV Pharmaceutical Recent Development
7.9 Lannett
7.9.1 Lannett Company Information
7.9.2 Lannett Introduction and Business Overview
7.9.3 Lannett Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Lannett Hydromorphone Product Offerings
7.9.5 Lannett Recent Development
7.10 Apotex
7.10.1 Apotex Company Information
7.10.2 Apotex Introduction and Business Overview
7.10.3 Apotex Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Apotex Hydromorphone Product Offerings
7.10.5 Apotex Recent Development
7.11 Fresenius
7.11.1 Fresenius Company Information
7.11.2 Fresenius Introduction and Business Overview
7.11.3 Fresenius Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Fresenius Hydromorphone Product Offerings
7.11.5 Fresenius Recent Development
7.12 Johnson and Johnson
7.12.1 Johnson and Johnson Company Information
7.12.2 Johnson and Johnson Introduction and Business Overview
7.12.3 Johnson and Johnson Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Johnson and Johnson Hydromorphone Product Offerings
7.12.5 Johnson and Johnson Recent Development
7.13 Mundipharma
7.13.1 Mundipharma Company Information
7.13.2 Mundipharma Introduction and Business Overview
7.13.3 Mundipharma Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Mundipharma Hydromorphone Product Offerings
7.13.5 Mundipharma Recent Development
7.14 Novartis
7.14.1 Novartis Company Information
7.14.2 Novartis Introduction and Business Overview
7.14.3 Novartis Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Novartis Hydromorphone Product Offerings
7.14.5 Novartis Recent Development
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Company Information
7.15.2 Stada Arzneimittel Introduction and Business Overview
7.15.3 Stada Arzneimittel Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Stada Arzneimittel Hydromorphone Product Offerings
7.15.5 Stada Arzneimittel Recent Development
7.16 Mylan
7.16.1 Mylan Company Information
7.16.2 Mylan Introduction and Business Overview
7.16.3 Mylan Hydromorphone Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Mylan Hydromorphone Product Offerings
7.16.5 Mylan Recent Development
8 Industry Chain Analysis
8.1 Hydromorphone Industrial Chain
8.2 Hydromorphone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hydromorphone Sales Model
8.5.2 Sales Channel
8.5.3 Hydromorphone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Hydromorphone Market Trends
    Table 2. Hydromorphone Market Drivers & Opportunity
    Table 3. Hydromorphone Market Challenges
    Table 4. Hydromorphone Market Restraints
    Table 5. Global Hydromorphone Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hydromorphone Revenue Market Share by Company (2019-2024)
    Table 7. Global Hydromorphone Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Hydromorphone Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Hydromorphone Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Hydromorphone Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Hydromorphone Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Hydromorphone
    Table 13. Global Hydromorphone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydromorphone as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Hydromorphone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Hydromorphone Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Hydromorphone Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Hydromorphone Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Hydromorphone Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Hydromorphone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Hydromorphone Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Hydromorphone Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Hydromorphone Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Hydromorphone Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Hydromorphone Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Hydromorphone Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Hydromorphone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Hydromorphone Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Hydromorphone Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Hydromorphone Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Hydromorphone Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Hydromorphone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Hydromorphone Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Hydromorphone Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Hydromorphone Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Hydromorphone Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Hydromorphone Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Hydromorphone Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Hydromorphone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Hydromorphone Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Hydromorphone Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Hydromorphone Sales Value by Region (2019-2024) & (%)
    Table 44. Global Hydromorphone Sales Value by Region (2025-2030) & (%)
    Table 45. Global Hydromorphone Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Hydromorphone Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Hydromorphone Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Hydromorphone Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Hydromorphone Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Hydromorphone Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Hydromorphone Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Hydromorphone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Hydromorphone Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Hydromorphone Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Hydromorphone Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Hydromorphone Sales Volume, (2025-2030) & (K Units)
    Table 57. Purdue Pharma Company Information
    Table 58. Purdue Pharma Introduction and Business Overview
    Table 59. Purdue Pharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Purdue Pharma Hydromorphone Product Offerings
    Table 61. Purdue Pharma Recent Development
    Table 62. Akorn Company Information
    Table 63. Akorn Introduction and Business Overview
    Table 64. Akorn Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Akorn Hydromorphone Product Offerings
    Table 66. Akorn Recent Development
    Table 67. Barr Pharmaceuticals Company Information
    Table 68. Barr Pharmaceuticals Introduction and Business Overview
    Table 69. Barr Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Barr Pharmaceuticals Hydromorphone Product Offerings
    Table 71. Barr Pharmaceuticals Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Hydromorphone Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Watson Laboratories Company Information
    Table 78. Watson Laboratories Introduction and Business Overview
    Table 79. Watson Laboratories Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Watson Laboratories Hydromorphone Product Offerings
    Table 81. Watson Laboratories Recent Development
    Table 82. Mallinckrodt Company Information
    Table 83. Mallinckrodt Introduction and Business Overview
    Table 84. Mallinckrodt Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Mallinckrodt Hydromorphone Product Offerings
    Table 86. Mallinckrodt Recent Development
    Table 87. Teva Pharmaceuticals Company Information
    Table 88. Teva Pharmaceuticals Introduction and Business Overview
    Table 89. Teva Pharmaceuticals Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Teva Pharmaceuticals Hydromorphone Product Offerings
    Table 91. Teva Pharmaceuticals Recent Development
    Table 92. KV Pharmaceutical Company Information
    Table 93. KV Pharmaceutical Introduction and Business Overview
    Table 94. KV Pharmaceutical Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. KV Pharmaceutical Hydromorphone Product Offerings
    Table 96. KV Pharmaceutical Recent Development
    Table 97. Lannett Company Information
    Table 98. Lannett Introduction and Business Overview
    Table 99. Lannett Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Lannett Hydromorphone Product Offerings
    Table 101. Lannett Recent Development
    Table 102. Apotex Company Information
    Table 103. Apotex Introduction and Business Overview
    Table 104. Apotex Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Apotex Hydromorphone Product Offerings
    Table 106. Apotex Recent Development
    Table 107. Fresenius Company Information
    Table 108. Fresenius Introduction and Business Overview
    Table 109. Fresenius Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Fresenius Hydromorphone Product Offerings
    Table 111. Fresenius Recent Development
    Table 112. Johnson and Johnson Company Information
    Table 113. Johnson and Johnson Introduction and Business Overview
    Table 114. Johnson and Johnson Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Johnson and Johnson Hydromorphone Product Offerings
    Table 116. Johnson and Johnson Recent Development
    Table 117. Mundipharma Company Information
    Table 118. Mundipharma Introduction and Business Overview
    Table 119. Mundipharma Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Mundipharma Hydromorphone Product Offerings
    Table 121. Mundipharma Recent Development
    Table 122. Novartis Company Information
    Table 123. Novartis Introduction and Business Overview
    Table 124. Novartis Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Novartis Hydromorphone Product Offerings
    Table 126. Novartis Recent Development
    Table 127. Stada Arzneimittel Company Information
    Table 128. Stada Arzneimittel Introduction and Business Overview
    Table 129. Stada Arzneimittel Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Stada Arzneimittel Hydromorphone Product Offerings
    Table 131. Stada Arzneimittel Recent Development
    Table 132. Mylan Company Information
    Table 133. Mylan Introduction and Business Overview
    Table 134. Mylan Hydromorphone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Mylan Hydromorphone Product Offerings
    Table 136. Mylan Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Hydromorphone Downstream Customers
    Table 140. Hydromorphone Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hydromorphone Product Picture
    Figure 2. Global Hydromorphone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Hydromorphone Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Hydromorphone Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Hydromorphone Report Years Considered
    Figure 7. Global Hydromorphone Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Hydromorphone Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hydromorphone Revenue in 2023
    Figure 10. Hydromorphone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. Injection Picture
    Figure 13. Global Hydromorphone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Hydromorphone Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Hydromorphone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Hydromorphone Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Hydromorphone Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drug Store
    Figure 20. Global Hydromorphone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Hydromorphone Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Hydromorphone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Hydromorphone Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Hydromorphone Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Hydromorphone Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Hydromorphone Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Hydromorphone Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Hydromorphone Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Hydromorphone Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Hydromorphone Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Hydromorphone Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Hydromorphone Sales Volume (%), (2019-2030)
    Figure 37. United States Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Hydromorphone Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Hydromorphone Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Hydromorphone Sales Value by Application (%), 2023 VS 2030
    Figure 58. Hydromorphone Industrial Chain
    Figure 59. Hydromorphone Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9U15196
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-14K1494
Thu Dec 12 00:00:00 UTC 2024

Add to Cart